Inhibrx Biosciences Insider Bought Shares Worth $1,523,620, According to a Recent SEC Filing

MT NewswiresNov 22, 2024 16:06 ET

JMP Securities Sticks to Their Hold Rating for Inhibrx Biosciences Inc (INBX)

TipRanksNov 18, 2024 00:26 ET

The Recent Drop in Prices Must Have Disappointed Inhibrx Biosciences, Inc. (NASDAQ:INBX) Institutional Investors Who Own 43% of the Shares

Yahoo FinanceNov 17, 2024 09:36 ET

Inhibrx Biosciences | 10-Q: Quarterly report

SECNov 14, 2024 17:20 ET · Announcements

Inhibrx Biosciences | 8-K: Inhibrx Biosciences Reports Third Quarter 2024 Financial Results

SECNov 14, 2024 16:32 ET

Express News | Inhibrx Q3 Operating Income USD -46.797 Million

ReutersNov 14, 2024 16:24 ET